| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.05 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.05 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.05 |